Can Fite Biopharma Ltd (NYSE American:CANF)
| 1.83 BATS BZX Real-Time Price As of 10:08am ET |  +0.011 / +0.60%Today’s Change | 1.08 Today|||52-Week Range 4.95 | -44.55% Year-to-Date |
Latest CANF News | Press Releases
No recent news for Can Fite Biopharma Ltd.
Today’s Trading
| Previous close | 1.82 |
| Today’s open | 1.89 |
| Day’s range | 1.83 - 1.89 |
| Volume | 102,677 |
| Average volume (3 months) | 1,145,960 |
| Market cap | $28.1M |
Data as of 10:08am ET, 10/19/2020
Growth & Valuation
| Earnings growth (last year) | +33.51% |
| Earnings growth (this year) | +65.76% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -46.46% |
| P/E ratio | NM |
| Price/Sales | 4.64 |
| Price/Book | 8.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCDABioCardia Inc | -0.01 | -0.43% |
| ---- | ||
| CLBSCaladrius Bioscience... | 0.00 | 0.00% |
| APVOAptevo Therapeutics ... | 0.00 | 0.00% |
Data as of 11:26am ET, 10/19/2020
Financials
| Next reporting date | November 25, 2020 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -471.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
